We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SYRS Syros Pharmaceuticals Inc

0.7029 (17.49%)
Last Updated: 15:11:14
Delayed by 15 minutes


Draw Mode:

Volume 768,906
Bid Price 4.72
Ask Price 4.75
News -
Day High 4.90


52 Week Range


Day Low 3.93
Company Name Stock Ticker Symbol Market Type
Syros Pharmaceuticals Inc SYRS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.7029 17.49% 4.7229 15:11:14
Open Price Low Price High Price Close Price Prev Close
4.00 3.93 4.90 4.02
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
4,266 768,906 $ 4.35 $ 3,347,219 - 2.0902 - 5.67
Last Trade Time Type Quantity Stock Price Currency
15:12:04 60 $ 4.7272 USD

Syros Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
99.86M 21.07M - 14.88M -94.65M -4.49 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Syros Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No SYRS Message Board. Create One! See More Posts on SYRS Message Board See More Message Board Posts

Historical SYRS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.744.902.473.90976,8411.9872.37%
1 Month2.954.902.473.73305,2751.7760.1%
3 Months3.944.902.09023.52141,0110.782919.87%
6 Months3.784.902.09023.5398,5780.942924.94%
1 Year3.385.672.09023.62105,5021.3439.73%
3 Years8.6915.64990.654.28558,174-3.97-45.65%
5 Years7.4515.64990.655.31451,193-2.73-36.61%

Syros Pharmaceuticals Description

Syros Pharmaceuticals Inc is a biopharmaceutical company engaged in a non-coding regulatory region of the genome controlling the activation and repression of genes. It is primarily involved in the segments of the pharmaceutical, biotechnology, and other related markets that address gene control and cancer. The Company operates only in the United States.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |